Deutsche Bank Downgrades Moderna (MRNA) to Hold Following Q2 Earnings Report
Tweet Send to a Friend
(Updated - August 3, 2023 9:14 AM EDT)
Deutsche Bank analyst Emmanuel Papadakis downgraded Moderna (NASDAQ: MRNA) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Deutsche Bank analyst Emmanuel Papadakis downgraded Moderna (NASDAQ: MRNA) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
